NCT06704191 2026-03-30In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE TrialMayo ClinicPhase 1/2 Recruiting40 enrolled
NCT06470282 2026-02-18Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder CancerUniversity of California, San FranciscoPhase 1/2 Recruiting47 enrolled